Eastman Chemical (EMN) EBIT (2009 - 2026)

Eastman Chemical (EMN) has 18 years of EBIT data on file, last reported at $188.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 37.75% year-over-year to $188.0 million; the trailing twelve-month figure through Mar 2026 stood at $662.0 million (down 49.73% YoY), and the FY2025 full-year result was $776.0 million, down 39.28% from the prior year.
• EBIT for Q1 2026 stood at $188.0 million, up from $64.0 million in the prior quarter.
• Across five years, EBIT topped out at $477.0 million in Q4 2023 and bottomed at $64.0 million in Q4 2025.
• The 5-year median for EBIT is $302.0 million (2025), against an average of $276.6 million.
• Peak annual rise in EBIT reached 860.71% in 2022, while the deepest fall reached 86.85% in 2022.
• A 5-year view of EBIT shows it stood at $76.0 million in 2022, then surged by 527.63% to $477.0 million in 2023, then declined by 26.83% to $349.0 million in 2024, then tumbled by 81.66% to $64.0 million in 2025, then surged by 193.75% to $188.0 million in 2026.
• The last three EBIT figures came in at $188.0 million (Q1 2026), $64.0 million (Q4 2025), and $188.0 million (Q3 2025), per Business Quant data.

Peer Comparison